Ana Beloqui

3.9k total citations · 1 hit paper
58 papers, 3.0k citations indexed

About

Ana Beloqui is a scholar working on Pharmaceutical Science, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ana Beloqui has authored 58 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pharmaceutical Science, 18 papers in Molecular Biology and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ana Beloqui's work include Advanced Drug Delivery Systems (30 papers), Drug Solubulity and Delivery Systems (14 papers) and RNA Interference and Gene Delivery (11 papers). Ana Beloqui is often cited by papers focused on Advanced Drug Delivery Systems (30 papers), Drug Solubulity and Delivery Systems (14 papers) and RNA Interference and Gene Delivery (11 papers). Ana Beloqui collaborates with scholars based in Belgium, Spain and Democratic Republic of the Congo. Ana Beloqui's co-authors include Véronique Préat, Maria Ángelés Solinís, Alicia Rodríguez‐Gascón, Anne des Rieux, Yining Xu, António J. Almeida, Patrick B. Memvanga, Neha Shrestha, Régis Coco and Aristote B. Buya and has published in prestigious journals such as ACS Nano, Biomaterials and Endocrine Reviews.

In The Last Decade

Ana Beloqui

54 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanostructured lipid carriers: Promising drug delivery systems for future clinics

2015 544 citations Ana Beloqui, Maria Ángelés Solinís et al. profile →

Peers

Ana Beloqui

BIOMA

El‐Sayed Khafagy Egypt

Dolores Torres Spain

Young Wook Choi South Korea

Ashim K. Mitra United States

Lars Hovgaard Denmark

Jaber Emami Iran

Deepti Pandita India

Chang‐Koo Shim South Korea

Kiran Sonaje Taiwan

Soo‐Jeong Lim South Korea

El‐Sayed Khafagy Egypt

Ana Beloqui

1.0k ×0.7

1.6k ×1.6

442 ×0.7

BIOMA

264 ×1.0

327 ×1.2

Citations per year, relative to Ana Beloqui Ana Beloqui (= 1×) peers El‐Sayed Khafagy

Countries citing papers authored by Ana Beloqui

Since Specialization

Citations

This map shows the geographic impact of Ana Beloqui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Beloqui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Beloqui more than expected).

Fields of papers citing papers by Ana Beloqui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Beloqui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Beloqui. The network helps show where Ana Beloqui may publish in the future.

Co-authorship network of co-authors of Ana Beloqui

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Beloqui. A scholar is included among the top collaborators of Ana Beloqui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Beloqui. Ana Beloqui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Cheng, et al.. (2025). Oral Lipid-Based Nanomedicine for the Inhibition of the cGAS-STING Pathway in Inflammatory Bowel Disease Treatment. Molecular Pharmaceutics. 22(4). 2108–2121. 1 indexed citations

Martín‐Saldaña, Sergio, et al.. (2025). Polypeptide-based multilayer capsules with anti-inflammatory properties: exploring different strategies to incorporate hydrophobic drugs. Journal of Materials Chemistry B. 13(18). 5297–5314. 2 indexed citations

Xu, Yining, Daniel J. Drucker, Giovanni Traverso, & Ana Beloqui. (2025). Innovative Molecules and Delivery Technologies Enabling the Future of GLP-1-based Therapies. Endocrine Reviews. 47(1). 1–23. 1 indexed citations

McCartney, Fiona, Yining Xu, Inês Domingues, et al.. (2024). An in situ bioadhesive foam as a large intestinal delivery platform for antibody fragment to treat inflammatory bowel disease. Journal of Controlled Release. 374. 254–266. 6 indexed citations

Feig, Vivian R., et al.. (2024). Designing for medication adherence in inflammatory bowel disease: multi-disciplinary approaches for self-administrable biotherapeutics. EClinicalMedicine. 77. 102850–102850. 4 indexed citations

Beloqui, Ana. (2024). Gut hormone stimulation as a therapeutic approach in oral peptide delivery. Journal of Controlled Release. 373. 31–37. 1 indexed citations

Pinto, Erveton P., Bernard Nysten, Leandro Rocha, et al.. (2023). Poly-ɛ-caprolactone nanocapsules loaded with copaiba essential oil reduce inflammation and pain in mice. International Journal of Pharmaceutics. 642. 123147–123147. 7 indexed citations

Domingues, Inês, Isabelle Leclercq, & Ana Beloqui. (2023). Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery. Journal of Controlled Release. 363. 415–434. 29 indexed citations

Neyrinck, Audrey M., Julie Rodriguez, Miriam Cnop, et al.. (2023). Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention. Diabetologia. 67(2). 333–345. 15 indexed citations

10.

Chen, Cheng, Ana Beloqui, & Yining Xu. (2023). Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease. Advanced Drug Delivery Reviews. 203. 115117–115117. 22 indexed citations

11.

Domingues, Inês, et al.. (2023). “Green” synthesized versus chemically synthesized zinc oxide nanoparticles: In vivo antihyperglycemic activity and pharmacokinetics. International Journal of Pharmaceutics. 650. 123701–123701. 10 indexed citations

12.

Beloqui, Ana, et al.. (2022). Mesenchymal stromal cells encapsulated in licensing hydrogels exert delocalized systemic protection against ulcerative colitis via subcutaneous xenotransplantation. European Journal of Pharmaceutics and Biopharmaceutics. 172. 31–40. 15 indexed citations

13.

Buya, Aristote B., et al.. (2021). Quality-by-Design-Based Development of a Voxelotor Self-Nanoemulsifying Drug-Delivery System with Improved Biopharmaceutical Attributes. Pharmaceutics. 13(9). 1388–1388. 16 indexed citations

14.

Buya, Aristote B., Ana Beloqui, Patrick B. Memvanga, & Véronique Préat. (2020). Self-Nano-Emulsifying Drug-Delivery Systems: From the Development to the Current Applications and Challenges in Oral Drug Delivery. Pharmaceutics. 12(12). 1194–1194. 172 indexed citations

15.

Buya, Aristote B., Bernard Učakar, Ana Beloqui, Patrick B. Memvanga, & Véronique Préat. (2020). Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDSs) for senicapoc. International Journal of Pharmaceutics. 580. 119180–119180. 38 indexed citations

16.

Plaza-Oliver, María, Ana Beloqui, Manuel J. Santander‐Ortega, et al.. (2020). Ascorbyl-dipalmitate-stabilised nanoemulsions as a potential localised treatment of inflammatory bowel diseases. International Journal of Pharmaceutics. 586. 119533–119533. 17 indexed citations

17.

Thwala, Lungile Nomcebo, Ana Beloqui, Noémi Csaba, et al.. (2016). The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach. Journal of Controlled Release. 243. 109–120. 43 indexed citations

18.

Beloqui, Ana, Régis Coco, Mireille Alhouayek, et al.. (2013). Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis. International Journal of Pharmaceutics. 454(2). 775–783. 121 indexed citations

19.

Beloqui, Ana, Maria Ángelés Solinís, Araceli Delgado, et al.. (2013). Biodistribution of Nanostructured Lipid Carriers (NLCs) after intravenous administration to rats: Influence of technological factors. European Journal of Pharmaceutics and Biopharmaceutics. 84(2). 309–314. 52 indexed citations

20.

Beloqui, Ana, Maria Ángelés Solinís, Araceli Delgado, et al.. (2013). Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution. Journal of Microencapsulation. 31(1). 1–8. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact